Versant Venture Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,561,150
| Closed | -$2.07M | – | 8 |
|
|
2024
Q3 | $2.07M | Hold |
3,561,150
| – | – | 3.25% | 6 |
|
|
2024
Q2 | $2.2M | Hold |
3,561,150
| – | – | 2.85% | 7 |
|
|
2024
Q1 | $9.15M | Hold |
3,561,150
| – | – | 8.87% | 4 |
|
|
2023
Q4 | $7.26M | Hold |
3,561,150
| – | – | 1.87% | 4 |
|
|
2023
Q3 | $6.13M | Hold |
3,561,150
| – | – | 3.26% | 5 |
|
|
2023
Q2 | $6.94M | Hold |
3,561,150
| – | – | 8.24% | 4 |
|
|
2023
Q1 | $9.9M | Hold |
3,561,150
| – | – | 20.64% | 2 |
|
|
2022
Q4 | $12.3M | Hold |
3,561,150
| – | – | 25.42% | 2 |
|
|
2022
Q3 | $9.15M | Hold |
3,561,150
| – | – | 15.6% | 2 |
|
|
2022
Q2 | $8.62M | Hold |
3,561,150
| – | – | 13.21% | 3 |
|
|
2022
Q1 | $14.7M | Hold |
3,561,150
| – | – | 14.65% | 3 |
|
|
2021
Q4 | $45.8M | Sell |
3,561,150
-444,744
| -11% | -$4.92M | 24.49% | 1 |
|
|
2021
Q3 | $43.3M | Sell |
4,005,894
-444,744
| -10% | -$4.05M | 17.91% | 3 |
|
|
2021
Q2 | $40.6M | Hold |
4,450,638
| – | – | 13.46% | 4 |
|
|
2021
Q1 | $42M | Hold |
4,450,638
| – | – | 8.18% | 5 |
|
|
2020
Q4 | $17.5M | Buy |
4,450,638
+1,347,709
| +43% | +$4.08M | 1.82% | 9 |
|
|
2020
Q3 | $8.22M | Hold |
3,102,929
| – | – | 1.51% | 8 |
|
|
2020
Q2 | $20.6M | Hold |
3,102,929
| – | – | 2.96% | 7 |
|
|
2020
Q1 | $18.1M | Hold |
3,102,929
| – | – | 4.95% | 5 |
|
|
2019
Q4 | $27.8M | Hold |
3,102,929
| – | – | 8.39% | 3 |
|
|
2019
Q3 | $26.8M | Hold |
3,102,929
| – | – | 10.37% | 3 |
|
|
2019
Q2 | $34.6M | Buy |
+3,102,929
| New | +$35.5M | 10.07% | 3 |
|
Other funds holding GRTS
Versant Venture Management's GRTS Position: Q4 2024 in Review
Versant Venture Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 3,561,150 shares — an estimated $2.07M sold.
Versant Venture Management first reported a position in GRTS in Q2 2019 and held it in 22 quarters. The position peaked at $45.8M in Q4 2021. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.
- Versant Venture Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Versant Venture Management sold 3,561,150 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $2.07M.
- Versant Venture Management first reported a position in Gritstone bio, Inc. Common Stock in Q2 2019 and held it in 22 quarters.
- Versant Venture Management's Gritstone bio, Inc. Common Stock position peaked at $45.8M in Q4 2021.
- 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.
Based on Versant Venture Management's 13F filing for Q4 2024, filed 12 Feb 2025.